PA (224-233), Influenza is a 10-aa peptide, a fragment of polymerase 2 protein in influenza A virus.
PA (224-233), Influenza is a synthetic peptide fragment corresponding to amino acids 224 through 233 of the polymerase acidic (PA) protein from the influenza virus. As a segment derived from an essential component of the viral RNA polymerase complex, this peptide holds significant value for researchers investigating influenza virus biology, host-pathogen interactions, and mechanisms of viral replication. The defined sequence enables precise interrogation of the PA protein's structure-function relationships, making it a critical reagent for a variety of virological and biochemical studies. Its use supports efforts to unravel the molecular determinants of influenza pathogenicity and to inform the development of novel antiviral strategies.
Epitope mapping: In immunological research, the PA (224-233) peptide is frequently utilized to identify and characterize antibody or T-cell epitopes within the influenza PA protein. By serving as a defined antigenic determinant, it facilitates the screening of immune responses in infected or vaccinated hosts, enabling the delineation of specific regions within the PA protein that are recognized by the adaptive immune system. Such insights are crucial for understanding immune surveillance mechanisms and for guiding the rational design of peptide-based vaccines or diagnostic assays.
Protein-protein interaction studies: The defined sequence of this peptide allows for targeted investigations into the molecular interactions between the PA protein and its cellular or viral partners. Researchers employ the PA (224-233) fragment in binding assays, pull-down experiments, or structural analyses to pinpoint interaction motifs that mediate the assembly or function of the influenza polymerase complex. These studies provide foundational knowledge for deciphering the mechanisms underlying viral transcription and replication, and for identifying potential sites of therapeutic intervention.
Antigen presentation assays: The PA (224-233) peptide serves as a valuable tool in studies of antigen processing and presentation, particularly in the context of major histocompatibility complex (MHC) class I or II pathways. By loading this peptide onto antigen-presenting cells, investigators can assess the efficiency of peptide presentation, T-cell activation, and the specificity of immune recognition. Such experiments contribute to a deeper understanding of host immune responses to influenza infection and inform strategies for enhancing cellular immunity through vaccination.
Peptide-based inhibitor screening: As a structurally defined segment of the PA protein, this peptide can be employed in high-throughput screening platforms to identify small molecules or biologics that disrupt its interactions or functions. By serving as a target in competitive binding assays or functional inhibition studies, it enables the discovery and characterization of candidate antiviral compounds that may interfere with critical steps in the influenza virus life cycle. This application is particularly relevant for early-stage drug discovery and the development of novel antiviral agents.
Structural and biophysical analyses: The PA (224-233) peptide is also instrumental in studies aimed at elucidating the conformational properties and stability of the PA protein's functional domains. Using techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD), or X-ray crystallography, researchers can probe the secondary structure, folding dynamics, and interaction surfaces of this region. These analyses yield detailed molecular insights that are fundamental for understanding the biophysical basis of influenza PA protein function and for guiding structure-based drug design efforts.
3. Emu oil in combination with other active ingredients for treating skin imperfections
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More